Compounds of formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.

 
Web www.patentalert.com

< Electrophoretic ink composed of particles with field dependent mobilities

< Therapeutic agents and methods of use thereof for the modulation of angiogenesis

> Bead polymerizates containing halogen-free phosphourus compounds

> Di-, tri-, and tetra-peptides having antiangiogenic activity

~ 00259